Investigational Drug Details
Drug ID: | D487 |
Drug Name: | Benzoyl peroxide |
Synonyms: | |
Type: | small molecule |
DrugBank ID: | DB09096 |
DrugBank Description: | Benzoyl peroxide (BPO) is an organic compound in the peroxide family. It is formed by two benzoyl groups which are connected by a peroxide link. It is one of the most important organic peroxides in terms of applications. In medicine, benzoyl peroxide is used as a topical treatment for acne, either in combination with antibiotics or as a single agent. These products are available over-the-counter or by prescription in gels, creams or liquids at concentrations of 2.5%, 5% or 10%. Benzoyl peroxide is also used for bleaching flour or hair, teeth whitening, for cross-linking polyester resins, and many other chemical uses. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. |
PubChem ID: | 7187 |
CasNo: | 94-36-0 |
Repositioning for NAFLD: | Yes |
SMILES: | O=C(OOC(=O)C1=CC=CC=C1)C1=CC=CC=C1 |
Structure: |
|
InChiKey: | OMPJBNCRMGITSC-UHFFFAOYSA-N |
Molecular Weight: | 242.2268 |
DrugBank Targets: | Catalase; NA; Arginine decarboxylase; Protein kinase C; NA |
DrugBank MoA: | Benzoyl peroxide decomposes to release oxygen after topical application. This oxygen acts as a bactericidal agent towards Proprionibacterium acnes, the bacteria present in acne vulgaris. Benzoyl peroxide also increases the turnover rate of epithelial cells, thereby peeling the skin and promoting the resolution of comedones. |
DrugBank Pharmacology: | Benzoyl peroxide acts as an antibacterial, irritant, keratolytic, comedolytic, and anti-inflammatory agent when applied topically to the human epithelium. |
DrugBank Indication: | Benzoyl peroxide is indicated for the treatment of mild to moderate acne vulgaris and rosacea. Combined with other agents, it may be used in the treatment of more severe acne. |
Targets: | |
Therapeutic Category: | |
Clinical Trial Progress: | |
Latest Progress: |

Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
---|
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
---|
Article ID | PMID | Source | Title |
---|